Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 • 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

January 21, 2022 • 00:41:39
Episode Cover

Bicarbonate Therapy in the Critically Ill Patient

In this podcast we are joined by EM/CCM superstars Dr. Gabe Wardi and Dr. Kit Tainter, who discuss the physiologic effects of metabolic acidosis,...

Listen

Episode 0

March 19, 2019 • 00:18:13
Episode Cover

BMV for ETI in the Critically Ill?

More than 1.5 million patients undergo endotracheal intubation each year in the U.S.  Endotracheal intubation can be complicated by hypoxemia, which is a known...

Listen

Episode 0

June 03, 2019 • 00:20:43
Episode Cover

Early Post-Cardiac Arrest Catheterization - The COACT Trial

A critical component to post-arrest care for the patient with ROSC following out-of-hospital cardiac arrest is early coronary angiography. Current guidelines recommend immediate cardiac...

Listen